Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI

Eledon Pharmaceuticals announced topline results from their Phase 2 trial of tegoprubart (formerly AT1501), a drug invented and developed at the ALS Therapy...

Related Keywords

Augie Nieto ,Fernandog Vieira ,Muscular Dystrophy Association ,Therapy Development Institute ,Department Of Defense ,Eledon Pharmaceuticals ,Development Institute ,Anelixis Therapeutics ,Drug Discovery Engine ,